April 14th 2020
Respiri Limited signs joint development agreement with Phenix Health, surges 50%
April 8th 2020
Non-elective treatment profile provides Avita Medical with income stability
March 25th 2020
Investors flock to Lifespot as a telehealth play
March 18th 2020
OncoSil granted FDA Breakthrough Device Designation
February 27th 2020
OncoSil on verge of CE Mark approval
December 4th 2019
HeraBEAT users could be in line for full refunds on the cost of the product
December 2nd 2019
HeraMED CEO David Groberman talks about the company’s progress
November 26th 2019
BPH ready to cash in on high profile energy investments
Connect with us
